{"DataElement":{"publicId":"7595961","version":"1","preferredName":"Mesothelioma Inflammation Pathologic Finding Other Specify","preferredDefinition":"Text field to capture the kind of inflammation related to mesothelioma.","longName":"7592034v1.0:2666713v2.0","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"7592034","version":"1","preferredName":"Mesothelioma Inflammation Pathologic Investigation Finding","preferredDefinition":"A usually malignant and aggressive neoplasm of the mesothelium which is often associated with exposure to asbestos._A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation._Caused by or altered by or manifesting disease or pathology._The result of an examination or inquiry.","longName":"7592019v1.0:7592032v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"7592019","version":"1","preferredName":"Mesothelioma","preferredDefinition":"A usually malignant and aggressive neoplasm of the mesothelium which is often associated with exposure to asbestos.","longName":"C3234","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mesothelioma","conceptCode":"C3234","definition":"A usually malignant and aggressive neoplasm of the mesothelium which is often associated with exposure to asbestos.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD3496FC-8BE2-0ED7-E053-4EBD850AF5D7","latestVersionIndicator":"Yes","beginDate":"2021-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-10","modifiedBy":"ONEDATA","dateModified":"2021-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7592032","version":"1","preferredName":"Inflammation Pathologic Investigation Finding","preferredDefinition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.:Caused by or altered by or manifesting disease or pathology.:The result of an examination or inquiry.","longName":"C3137:C25610:C61036","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Investigation Finding","conceptCode":"C61036","definition":"The result of an examination or inquiry.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD33D936-2FFC-7DF8-E053-4EBD850A2BD0","latestVersionIndicator":"Yes","beginDate":"2021-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-10","modifiedBy":"ONEDATA","dateModified":"2021-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD33D936-300D-7DF8-E053-4EBD850A2BD0","latestVersionIndicator":"Yes","beginDate":"2021-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-10","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeDescription":"Created for HCMI: Mesothelioma Curation Request 2.25.2021 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2666713","version":"2","preferredName":"Other Specify","preferredDefinition":"Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.","longName":"OTH_SPEC","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208051","version":"1","preferredName":"Other Specify","preferredDefinition":"Not otherwise specified.:Specify; be specific about something; define clearly.","longName":"C17649:C25685","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3B5E-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"132D4785-528E-5337-E050-BB89AD433CA8","latestVersionIndicator":"Yes","beginDate":"2015-04-07","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"HARTLEYG","dateModified":"2018-06-06","changeDescription":"7/19/17 jk transferred context and added registration status, CSI per Round 5 finalization task. 4/28/15 released. jc  4/7/15 VD versioned per COG WG: inc to 100 char, remove min limit, chg concept domain to assessment result. jc 1/25/13 added ACRIN Old caBIG CSI.  3/21/12 - changed origin from IVI to ACRIN.  3/5/08 - released for UoWASH FES CRF.   7/23/07-created for ACRIN PET CDEs","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"7589447","version":"1","longName":"Mesothelioma","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Specify inflammation type","type":"Preferred Question Text","description":"Specify inflammation type","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD986F2E-3CC3-3EA6-E053-4EBD850A8D85","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeDescription":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}